Study Looks at Efficacy of Hemoglobin Thresholds for Transfusion

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 1, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 1, 2024 -- For patients with acute myocardial infarction (MI) and anemia, 30-day risks for death or recurrent MI seem to increase with lower hemoglobin thresholds for transfusion, according to a study published online Oct. 1 in the Annals of Internal Medicine.

Gerard T. Portela, Ph.D., from the University of Pittsburgh, and colleagues estimated the efficacy of four individual hemoglobin thresholds (<10 g/dL, <9 g/dL, <8 g/dL, and <7 g/dL) to guide transfusion in patients with acute MI and anemia in a secondary analysis of the Myocardial Ischemia and Transfusion (MINT) trial conducted in 144 sites in six countries. Data were included for 3,492 MINT trial participants with acute MI.

The researchers found that the 30-day risk for death or recurrent MI (death/MI) was 14.8, 15.1, 15.9, and 18.3 percent for a <10-g/dL, <9-g/dL, <8-g/dL, and <7-g/dL strategy, respectively. Relative to the <10-g/dL strategy, the absolute risk differences and risk ratios increased as thresholds decreased, although the 95 percent confidence intervals were wide. Similar and imprecise findings were seen for 30-day death.

"The imprecision of these estimates, however, prevents explicit recommendations about individual hemoglobin transfusion thresholds," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-02 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords